Nicholas Chronos, MD, FRCP, FACC, FESC, FAHA - Chairman
Dr. Chronos serves as the Chief Scientific and Medical Officer of the Saint Joseph's Research Institute (SJRI) at Saint Joseph's Hospital in Atlanta, where he directs and concurrently oversees pre-clinical and clinical trials. Dr. Chronos practices Interventional Cardiology with the Atlanta Cardiology Group (at Saint Joseph's Hospital of Atlanta), is a distinguished Adjunct Professor of Cardiology and Medicine at Duke University and is a renowned faculty member and speaker at major medical conferences both nationally and internationally.
He is a Fellow of the Royal College of Physicians (London), the American College of Cardiology, the European Society of Cardiology and the American Heart Association. He received his Bachelors degree in Medicine and Surgery from the Royal Free Hospital School of Medicine in London in 1987, and subsequently trained in cardiology and interventional cardiology at the Royal Brompton National Heart and Lung Institute under the direction of Professors Ulrich Sigwart and Anthony Rickards.
In 1992, he was awarded the British Heart Foundation International Fellowship and furthered his research in Thrombosis and Interventional Cardiology at Emory University School of Medicine, under the direction of Spencer B. King, III, M.D. In 1997 he was named Director of Research at the Andreas Gruentzig Cardiovascular Center at Emory University Hospital.
In addition, Dr. Chronos has served on numerous committees at the National Institutes of Health as well as a Study Section Member and Chair for the Center for Scientific Review Cardiovascular Science and SBIR. In 2006, he became a member of the NIH Recombinant DNA Advisory Committee. He has served on the Data Safety Monitoring Board (ClinTrials Research), NIRVANA (Boston Scientific), and SCORES (Scimed Life Systems). Dr. Chronos currently serves as a Board Member on multiple Scientific Advisory Boards including METRONIC VASCULAR, BIOHEART Inc., SYMPHONY MEDICAL, VIACELL, ATLANTA BIOTECH NETWORK, ACTx, PROTEUS BIOMEDICAL, and CELTAXSYS.
Distinguished world-wide for his pioneering research in angiogenesis, Dr. Chronos was named Co-National Principal Investigator on the FIRST (Chiron Corporation) study, the largest human clinical trial of angiogenesis. Presently he serves as Principal Investigator for two large clinical trials that use autologous stem cells to repair damaged cardiac muscle. His prominent work on the MYOHEART (Myogenesis Heart Efficiency and Regeneration Trial) has received widespread media attention nationwide. He has also served on the Steering Committees for various scientific studies such as such as RFPMR (Boston Scientific), and TARGET (Merck & Co., Inc.).
Michael Dake, M.D.
Professor Michael Dake, USA, received his medical degree from Baylor College of Medicine, Houston, 1978, where he did an internship and residency in Internal Medicine 1978-1982 followed by a fellowship in Pulmonary Medicine at University of California, San Francisco, 1982-1983. He then entered a residency in Radiology and did a fellowship in interventional Radiology at UCSF 1986-1987. The year following his fellowship, he worked at San Francisco General Hospital before moving to Miami in 1988 to join Barry T. Katzen at the newly founded Miami Vascular Institute.
In 1990, Professor Dake assumed the positions of Section Chief of Cardiovascular and Interventional Radiology, and Co-director of the Catheterization and Angiography Laboratories at Stanford University Hospital. Over the next 15 years at Stanford, he directed a team of interventionalists, who collaborated with specialists in other disciplines to achieve a number of noteworthy accomplishments. In 2005, Professor Dake assumed the role of Chairman of the Department of Radiology, Professor of Radiology at the University of Virginia Health System and professorial appointments in the Department of Medicine (Pulmonary Diseases) and Surgery at the School of Medicine in Charlottesville. In 2008, he returned to Stanford where he now is Professor of Cardiothoracic Surgery and Medical Director of the Catheterization and Angiography Laboratories at Stanford Medical Center.
Bart Dolmatch, M.D.
Dr. Dolmatch, Professor of Radiology and Director of Interventional Radiology at the University of Texas Southwestern Medical Center in Dallas, has practiced interventional radiology for nearly 20 years. Following radiology residency at the University of California in San Francisco in 1988, he was the first Interventional Radiology fellow at the Miami Vascular Institute (now the Baptist Cardiac and Vascular Institute).
From 1989-1995 he served as co-director of the Interventional Radiology service at the Washington Hospital Center in Washington, D.C. Between 1995 and 2000, Dr. Dolmatch directed the Interventional Radiology service at the Cleveland Clinic Foundation, during which time he developed basic and clinical research programs for the study of removable IVC filters, stent-grafts for medium sized blood vessels, and the development of liquid embolic agents. In 2000, Dr. Dolmatch was appointed Professor of Radiology at the University of Texas Southwestern Medical Center, Dallas, TX. Since then, he has built the Interventional Radiology Division from its initial group of three faculty to its current cohort of seven full-time physicians. He is program director for the UTSW Interventional Radiology fellowship training program.
Current areas of research interest include endovascular approaches to hemodialysis access, treatment of venous disease, new technical advances in embolotherapy, and expanded use of CT angiography for all facets of vascular disease. He co-directs the international conference “Controversies in Dialysis Access” that brings together surgeons, nephrologists, and radiologists, and speaks regularly at other national and international vascular meetings.
Mark Glickman MD, FACS
Dr. Glickman received his medical degree from Case Western Reserve University and finished his general surgery residency at the University of Washington Hospitals in Seattle, Washington. In 1981 Dr. Glickman completed his vascular surgery fellowship at Saint Anthony Hospital in Columbus, Ohio, and joined Vascular & Transplant Specialists (formerly known as Virginia Vascular Associates) where he serves as a member of its board of directors and the group's managing director. He is certified by the American Board of Surgery in both general surgery and vascular surgery.
Dr. Glickman has held academic appointments at Ohio State University, Eastern Virginia Medical School and Old Dominion University. He has co-authored and published numerous vascular disease and vascular surgery articles and has presented papers to surgical societies around the world.
Dr. Glickman is a Fellow of the American College of Surgeons (FACS). He is the medical director of the Peripheral Vascular Laboratory at Chesapeake General Hospital. Dr. Glickman also serves as the medical director for Sentara's Southside hospitals' vascular services. He directs Vascular & Transplant's amputee rehabilitation unit and the group's industry-sponsored clinical research programs. As a result of his research into vascular access, Dr. Glickman is regularly invited to speak on the subject at national and international medical conferences.
Dr. Robert J. Robbins, MD.
Dr. Robert C. Robbins is the president and CEO of the Texas Medical Center. He attended the University of Mississippi Medical Center where he received his MD and completed his general surgical training. He completed his Cardiothoracic Surgery Residency at Stanford University.
In addition to his work at Texas Medical Center, Dr. Robbins is also a manuscript reviewer for a number of prestigious journals including the New England Journal of Medicine, Annals of Thoracic Surgery, and the Journal of Thoracic and Cardiovascular Surgery. He also serves on the editorial board of the Journal of Thoracic and Cardiovascular Surgery, Cardiac Surgery Digest, the Journal of Heart and Lung Transplantation, and Innovations.